COVID-19 and substance use disorders : Recommendations to a comprehensive healthcare response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group position paper
MetadataShow full item record
Coronavirus disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who Use Drugs (PWUD) are a marginalized and stigmatized group with weaker immunity responses, vulnerability to stress, poor health conditions, high-risk behaviors, and lower access to health care services. These conditions put them at a higher risk of COVID-19 infection and its complications. In this paper, an international group of experts on addiction medicine, infectious diseases, and disaster psychiatry explore the possible raised concerns in this issue and provide recommendations to manage the comorbidity of COVID-19 and Substance Use Disorder (SUD).
Farhoudian , A , Baldacchino , A M , Clark , N , Gerra , G , Ekhtiari , H , Dom , G , Mokri , A , Sadeghi , M , Nematollahi , P , Demasi , M , Schütz , C G , Hashemian , S M , Tabarsi , P , Galea-Singer , S , Carrà , G , Clausen , T , Kouimtsidis , C , Tolomeo , S , Radfar , S R & Razaghi , E M 2020 , ' COVID-19 and substance use disorders : Recommendations to a comprehensive healthcare response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group position paper ' , Basic and Clinical Neuroscience , vol. Special Issue on COVID-19 , pp. 129-146 . https://doi.org/10.32598/bcn.11.covid19.1
Basic and Clinical Neuroscience
Copyright © 2020 The Authors. This is an open access article under the terms of the Creative Commons Attribution NonCommercial License, which permits non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.
Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.